EGFR Exon 19-del | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Director New Product Planning

Morphosys

Click here for more information

Conferences Trial results

18 October 2023

ESMO 2023 – butterflies for J&J

Rybrevant underwhelms in Mariposa, handing a possible advantage back to AstraZeneca’s Tagrisso.

Subscribe to EGFR Exon 19-del